Myriad Genetics CEO Paul J. Diaz to Present at Bank of America Securities 2021 Virtual Health Care Conference

Rhea-AI Summary

Myriad Genetics (NASDAQ: MYGN) will present its transformation plan and growth initiatives at the Bank of America Securities 2021 Virtual Health Care Conference on May 12, 2021, at 2:45 p.m. EDT. CEO Paul J. Diaz will lead the discussion, which will be accessible via a live audio webcast. Myriad Genetics focuses on genetic testing and precision medicine, aiming to enhance patient lives through molecular diagnostic tests that assess disease risks, diagnoses, and treatment decisions. For more details, visit www.myriad.com.

SALT LAKE CITY, May 05, 2021 (GLOBE NEWSWIRE) -- Paul J. Diaz, president and CEO of Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will discuss the company’s transformation plan and growth initiatives during a fireside chat at the Bank of America Securities 2021 Virtual Health Care Conference at 2:45 p.m. EDT on May 12, 2021.

The presentation will be available via a live audio webcast accessible at the following direct link (link) or through the investor information section of Myriad’s website at www.myriad.com.

About Myriad Genetics
Myriad Genetics Inc., is a leading genetic testing and precision medicine company dedicated to improving and transforming patient lives worldwide. Myriad discovers and commercializes molecular diagnostic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs. For more information, please visit the company's website: www.myriad.com.

Myriad, the Myriad logo, BART, BRACAnalysis, Colaris, Colaris AP, myPath, myRisk, Myriad myRisk, myRisk Hereditary Cancer, myChoice, myPlan, BRACAnalysis CDx, Tumor BRACAnalysis CDx, myChoice CDx, Vectra, Prequel, Foresight, GeneSight, riskScore and Prolaris are trademarks or registered trademarks of Myriad Genetics, Inc. or its wholly owned subsidiaries in the United States and foreign countries. MYGN-F, MYGN-G.

Media Contact:	Jared Maxwell	Investor Contact:	Scott Gleason
	(801) 505-5027		(801) 584-1143
	jmaxwell@myriad.com		sgleason@myriad.com

 

                      
                                                          
                                                        

 

FAQ

What is the date and time for the Myriad Genetics presentation at the Bank of America Securities 2021 Virtual Health Care Conference?

The presentation is scheduled for May 12, 2021, at 2:45 p.m. EDT.

Who will be speaking at the Myriad Genetics presentation at the Bank of America conference?

Paul J. Diaz, president and CEO of Myriad Genetics, will speak at the presentation.

Where can I watch the Myriad Genetics presentation live?

The presentation will be available via a live audio webcast accessible on Myriad's website.

What topics will Myriad Genetics cover during the conference presentation?

Myriad Genetics will discuss its transformation plan and growth initiatives.

What is the stock symbol for Myriad Genetics?

The stock symbol for Myriad Genetics is MYGN.